KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Finished Goods: 2018-2025

Historic Finished Goods for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to $5.9 million.

  • Twist Bioscience's Finished Goods rose 26.80% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 26.80%. This contributed to the annual value of $5.9 million for FY2025, which is 26.80% up from last year.
  • Latest data reveals that Twist Bioscience reported Finished Goods of $5.9 million as of FY2025, which was up 26.80% from $4.6 million recorded in FY2024.
  • Over the past 5 years, Twist Bioscience's Finished Goods peaked at $8.2 million during FY2021, and registered a low of $3.9 million during FY2023.
  • Its 3-year average for Finished Goods is $4.8 million, with a median of $4.6 million in 2024.
  • In the last 5 years, Twist Bioscience's Finished Goods soared by 693.89% in 2021 and then crashed by 48.71% in 2023.
  • Over the past 5 years, Twist Bioscience's Finished Goods (Yearly) stood at $8.2 million in 2021, then declined by 6.49% to $7.7 million in 2022, then slumped by 48.71% to $3.9 million in 2023, then climbed by 17.58% to $4.6 million in 2024, then rose by 26.80% to $5.9 million in 2025.